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Summanr A nested lung cancer case-control study was carried out using 397 12 h unrne samples originally
collected from a cohort of over 26 000 women aged 40-64 at entry who were then followed for up to 15 years.
The urine samples from active smokers were first identified using a simple qualitative method and their total
nicotine metabolites creatinine ratios then determined by automated colorimetric methods. The results
obtained demonstrated the capacity of nicotine metabolite estimations in a single 12 h sample of unrne to
predict the subsequent risk of lung cancer. The risk of lung cancer among the biochemically proven active
smokers during this period was 7.8 times that of the non-smokers, suggesting that the dose-response
relationship between smoking and lung cancer is no less steep in women than in men. The smoking-related risk
of adenocarcinoma was less than that of other lung carcinomas. It is suggested that this biochemical
epidemiology approach to exploring the relationship between smoking and lung cancer could profitably be
applied to the study of other smoking-related diseases.
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The limitations to studying the dose dependence of lung
cancer among active or passive smokers using self-reported
daily cigarette consumptions or exposures to environmental
tobacco smoke have been discussed in our companion paper
(De Waard et al., 1995). This paper then described the
successful application of a direct biochemical epidemiological
approach in which the risks ofdeveloping lung cancer among
both active and passive smokers were shown to be highly
correlated with the ratios ofcotinine,/creatinine in single 12 h
urine samples collected up to 15 years previously.
Previously the most widely used direct methods for assess-
ing the relative inhalation of tobacco smoke by active
smokers have been to determine the plasma, salivary or
urinary concentrations of the nicotine metabolite cotinine
using either gas-liquid chromatographic or radioimmunoassay
methods (Hill et al.. 1983; Jarvis et al.. 1984; Russell et al.,
1986; Armitage et al.. 1988; Wall et al.. 1988; Woodward et
al.. 1991). Simpler. cheaper and more rapid manual and
automated colorimetnrc methods have also been reported to
identify active smokers and to estimate their unrnary con-
centrations of nicotine together with cotinine and all their
other pyridyl-containing metabolites (total nicotine meta-
bolites. TNM) (Peach et al.. 1985; Barlow et al., 1987;
Puhakainen et al., 1987; Withey et al.. 1992).
Studies of cotinine blood levels (Benowitz et al., 1983),
comparisons of nicotine blood levels after intravenous
dosage and ad libitum smoking (Benowitz and Jacob, 1984)
and urinary TNM excretion (Peach et al., 1985) have all
shown that individual smokers differ greatly in the effic-
iencies with which they smoke their cigarettes. Recently
studies employing gas chromatography-mass spectrometry
(GC-MS) techniques for specifically estimating all the
major metabolites of nicotine have shown that the propor-
tions of inhaled nicotine doses eliminated in the urine as
cotinine by active smokers vary greatly between individuals
(Byrd et al., 1992; Benowitz et al., 1994). Such findings
indicate that total nicotine metabolite measurements should
provide more accurate estimates of relative nicotine tar
intakes than cotinine determinations. This paper reports a
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case-control study of the relationship between lung cancer
risk and urinary TNM/creatinine ratios among self-reported
and biochemically proven active smokers in a cohort of
Dutch women using the same 12 h urine samples whose
cotimine concentrations were reported in our compamion
paper (De Waard et al., 1995).
Participants and methds
In 1974 a population-based screening programme was
initiated for the early detection of breast cancer in a cohort
of over 26 000 women aged 40-64 living in the city of
Utrecht (the DOM project). From each participant a 12 h
urine sample was collected which covered the night before
attending screening and stored thereafter at -20°C.
In the framework of evaluating the DOM project we
established a mortality register (all causes) with the
cooperation of all the general practitioners in the city of
Utrecht. It was also possible to make use of The Nether-
lands Cancer Registry. Linkage with this register was per-
formed in such a way that legal requirements for privacy
protection were met. This gave the opportunity to perform
a nested case-control study.
During 15 years' follow-up 92 lung cancer cases were
found in this cohort. For each case 2-4 controls were
selected by computer, having about the same age and day
of urine collection. Thus, the material for biochemical
analysis consisted of urine samples from 92 lung cancer
cases and 305 controls. A detailed description of the ident-
ification of the lung cancer cases, logistics of the collection
and retrieval of the urine samples, and the GC-MS deter-
mination of their cotimine concentrations is given in the
accompanying paper (De Waard et al.. 1995).
Analytical methods
Active smokers were identified at the National Institute for
Medical Research, London, UK by testing all the urine
samples using the qualitative diethylthiobarbituric acid ext-
raction method for the presence of nicotine and its pyridyl-
containing metabolites (Peach et al., 1985). A positive result
was indicated by the presence of pink-red chromophores
that largely partitioned into the ethyl acetate phase.
The concentrations of total nicotine metabolites (TNM as
cotinine) and creatinine in the positive urine samples wereNicoine meabolites and lung cancer risk
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then determined bv automated versions (Puhakainen et al..
1987) of the original manual direct barbituric acid and
alkaline picrate methods (Peach et al.. 1985). A set of nine
aqueous standards containing 2. 4. 6. 8. 10. 12. 14. 16 and
18 mg I` cotinine together With 0.3. 0.6. 0.9. 1.2. 1.5. 1.8.
2.1. 2.4 and 2.7 g 1-1 creatinine. respectively, were proc-
essed with each set of urine samples. Samples with concen-
trations in excess of the top standards were appropriately
diluted and reassayed. Apparent urinary TNM creatinine
ratios were calculated (jig TNM mg-' creatinine) to allow
for the influence of diuresis and then corrected by subtract-
ing a mean 'blank' value of 1.1 determined when the proce-
dure was applied to a random selection of 200 samples from
non-smokers giving negative qualitative tests.
Data anal!sis
Data analysis A-as performed at the Department of
Epidemiology. University of Utrecht. With an Olivetti PCS 33
using SPSS version 4.0.1.
Self-reported smokers were divlided into tertiles according
to their then reported daily cigarette consumptions (< 10.
10-20 and >20). Odds ratios for the risk of lung cancer in
these tertiles were calculated using self-reported non-smokers
as the reference group. after exclusion of self-reported ex-
smokers. Subjects shown to be active smokers from the
positive qualitative tests given by their urine samples were
classified into tertiles according to their TNM creatinine
ratios. Odds ratios of lung cancer risk in these tertiles were
calculated using non-smokers (negative qualitative test) as the
reference group. To facilitate comparison of the lung cancer
risks based on cigarette consumptions or on TNM creatinine
ratios, analyses of the latter results were restricted to subjects
from whom smoking histories had been obtained. Odds
ratios were also calculated for different types of lung carc-
inoma.
Results
Urinary excretion ofcotinine and TAM according to declared
smoking habits and identification ofactive smokers
The results obtained using the qualitative diethylthiobar-
bituric acid extraction procedure and the ranges of urinary
TNM creatinine ratios according to the women's declared
smoking status at the time of urine collection are summarised
in Table I. Among the controls 30% were self-reported
smokers. None of the 208 urine samples collected from the
women who reported being non-smokers gave a positive
diethylthiobarbituric acid qualitative test (100% sensitivity).
The specificity of the qualitative test according to self-
reported smoking status was 910%. Thus all but one of the 85
urine samples from women who reported smoking ten or
more cigarettes a day gave positive qualitativ, tests. However
among the urine samples from 32 women reported smoking
less than ten cigarettes a day. nine gave negative qualitative
tests and had cotinine concentrations averaging only 37
gg 1-'. well below those typical of active smokers (De Waard
et al.. 1995). They were therefore probably in reality non-
addicted 'social' smokers. Furthermore three of the cited
positive results. with concomitant cotinine concentrations of
91 -121 tLg I'. were read as doubtful positives. the onlv such
readings in the w-hole study. A comparison of the results of
the qualitative tests and the concomitant urinary cotinine
concentrations indicated that the cut-off point for the
qualitative test was equivalent to a concomitant cotinine
concentration of about 100 gg I1. The robustness and
precision of the qualitative test was indicated by the fact that
only 2 of the 218 samples giving negative results had con-
comitant cotirine concentrations of greater than 100 gg 1-'
(112 and 125glg I) Similarly only 2 of the 107 samples
giving positive results had concentrations of less than this
value (70 and 75 Ag 1`).
The results presented in Table I also demonstrate the wide
ranges of nicotine intake in each of the three reported smok-
ing categories as well as its flattening off with increasing
cigarette consumption. Pairs of urine samples collected over
an interval of 1 year were available from 29 confirmed
smokers in the first wave of cases and controls (see Methods
section in De Waard et al.. 1995). The Pearson correlation
coefficient for the corresponding pairs of TNM creatinine
ratios. using logarithmically transformed data was 0.73 (95%
CI 0.51-0.86). showing the relative stability of indiVidual
nicotine intakes during this period. A one way analysis of
variance of the ratios of cotinine TNM of these 29 pairs of
samples showed that there were significant individual diff-
erences (P = 0.001) in the proportions of total nicotine
metabolites eliminated as cotinine. which ranged from 6% to
31% (mean 15%).
Reported cigarette consumption and lung cancer risk
Table I shows that overall self-reported current smokers had
an odds ratio of 6.3 (95% CI 3.5-11.4) for risk of lung
cancer as compared with those reported to be non-smokers.
It also shows the much lower risk (odds ratio 1.3. 95% CI
0.4-4.2) of those smokers who reported smoking fewer than
ten cigarettes a day.
TNMv excretion and lung cancer risk
The increasing risk of lung cancer as a function of increasing
TNM creatinine ratios among smokers is shown in Table II.
Thus the odds ratios among the three tertiles were 0.9 (95%
CI 0.2-3.1). 14.1 (95% CI 6.2-31.7) and 18.8 (950 CI
8.2-42.9) respectively.
Histological tipe and lung cancer risk in relation to smoking
Data on histological type of lung cancer were available
through the cancer registry for 49 of the patients (De Waard
et al.. 1995). Relative risk in relation to cotinine and TNM
excretion was computed separately for adenocarcinoma in
contrast to the sum of other histological types. The results
are summarised in Table III and show that the relationship
with smoking is much weaker for adenocarcinoma of the
lung than for the other pulmonary cancers.
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Table I Estimates of relative nicotine intake andrisk of lung cancer according to reported cigarette consumption
Daili reported TN.C in positive
cigarette Number of Positive urine samples. range Lung cancer Odds ratio
conswnption subjects" test: n 0% (geometric mean) cases controls 95% CI,
Nil 208 0 (0) 20 188 1.0
<10 32 23 (72) 1.6-22.4 (6.5) 4 28 1.3 (0.4-4.2)
10-20 57 56 (98) 3.2-29.3 (13.2) 29 28 9.7 (4.9-19.5) >20 28 28 (100) 4.4-25.6 (14.5) 14 14 9.4 (3.9-22.5)
All smokers 117 107 (91) 1.6-29.3 (11.8) 47 70 6.3 (3.5-11.4)
Total 325 107 (33) 67 258
'Subjects With missing reported cigarette consumptions as well as ex-smokers are excluded. 'tg total nicotine
metabolites mg- creatinine. TNM. total nicotine metabolites.
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Table I Risk oflung canceraccording tourinaryexcretion oftotal nicotine metabolites
m actave smokers
Urinary TNMpgmg creatinine'
range Lng cancer
(geometric mean) cases Controls Odds ratio (95% CI)
Non-smokerse 21 197 1.0
1.6-9.9 (5.8) 3 32 0.9 (0.2-3.1)
10.1-17.6 (13.7) 21 14 14.1 (6.2-31.7)
17.7-29.3 (21.3) 24 12 18.8 (8.2-42.9)
All smokers (12.0) 48 58 7.8 (4.3-14.0)
Total 69 255
'Samples giving negative qualitative tests. TNM, total nicotine metabolites.
Table M Odds ratios in relation to TNM excretion for different types of lung
cancer
OR adenocarcinomas OR other carcinomas
TNM (pgmg-' creatinine) (95% CI) (95% CI)
Non-snokerse 1.0 1.0
1.6-9.9 No OR estiMateb 1.0 (0.1-9.1)
10.1-17.6 14.4 (2.5-81.3) 22.0 (6.1-79.8)
17.7-29.3 6.2 (1.4-26.6) 17.6 (4.4-71.0)
All smokers 4.9 (1.6-14.4) 10.5 (3.8-29.3)
'Samples giving negative qualitative tests. bNo cases among (light) smokers.
The excellent results obtained using the simple qualitative
diethylthiobarbituric acid extraction procedure to distinguish
between active smokers on the one hand, and non-smokers
and passive smokers on the other, confirms the original
results obtained using the method (Peach et al., 1985). It is
noteworthy that the cut-off point for the qualitative test
occurred at concomitant cotinine concentrations of about
lOOIpg 1-', a level similar to the optimal cut-off point (about
70 pg 1-1) based on self-reported smoking status and urinary
cotinine concentrations (De Waard et al., 1995). These cut-
off points are also similar to that (50 pg 1-') recom ed
by Jarvis et al. (1987) and a value of about 128pg 1-'
suggted by the results obtained by Wald et al. (1984).
Tbese findings therefore indicate that the simple, cheap
diethylthiobarbituric acid extraction procedure, which has a
potential throughput of greater than 60 samples per hour, is
at kast as efficient at identifying active smokers as the much
more technicilly demanding cotinine-based procedures.
The results presented in Tables I and H show that the
slightly higher odds ratio for the risk of lung cancer in
biochemically proven smokers (7.8) as compared with a value
of 6.3 for self-admitted smokers arose through the presence
of a significnt proportion (9%) of very light smokers. Since
their nicotine intakes were siilar to those of more heavily
exposed passive smokers (De Waard et al., 1995) it is sugg-
ested that they were probably non-addicted social smokers.
By contrast with numerous other studies reported in the
literature it is noteworthy that the women followed in our
study were remarkably truthful in reporting their smoking
status. Thus not a single active smoker was identified among
the self-reported non-smokers. Such 'deceivers' (Jarvis et al.,
1987) can considerably complicate the interpretation of
questionnaire-based epidemiological investigations and pro-
vide an important incentive for using the direct biochemical
epidemiology approach. The absence of deceivers in our
study may well be due to the fact that when the smoling
histories were obtained (1975-83) there was much less public
awareness of the health dangers of smoking.
Another reason that TNM/creatinine ratios should provide
a much better esfimate of smoke intake and therfore a
steeper dose-response curve for lung cancer risk than self-
reported cigarette consumption is the previously described
evidence for the greatly differing efficiencies with which indiv-
iduals smoke their cigarettes. To test whether this might have
been the case, the biochemically proven active smokers were
divided according to their TNM/creatinine ratios into une-
qual tertils so as to match the proportions of smokers in the
three self-reporting categories set out in Table I. However a
chi-squared analysis showed that the dose-dependent risk
relationship based on TNM/creatnine ratios [odds ratios of
1.1 (0.3-3.9), 8.6 (4.2-17.8) and 29.5 (11.3-77.2) respect-
ively], was not significantly steeper (P = 0.11) than that based
on cigarette consumptions [1.3 (0.4-4.2), 9.7 (4.9-19.5) and
9.4 (3.9-22.5) respectively].
A comparison of the odds ratios for lung cancer risk
among equal tertiles of active smokers based on TNM/
creatinine ratios set out in Table II (0.9, 14.1 and 18.8
respectively) with the corresponding odds ratios (1.3, 10.3
and 9.8 respectively) based on cotinine/creatinine ratios (De
Waard et al., 1995) shows that the simpler colorimetric
method for estimating total nicotine metabolites performed
at least as weil in demonstrating the dose dependence of
smoking-related lung cancer risk as the highly sophisticated
GC-MS method for estmating cotinine.
The eviden obtained in our study demonstrating the
large individual differences in the proportions of inhaled
nicotine excreted as cotinine confirms the findings of Byrd et
al. (1992) and Benowitz et al. (1994).
At first sight it might seem surprising that single estimates
of urinary nicotine metabolite excretion were so predictive of
subsequent lung cancer risk. However there is a considerable
body of indit evidence to suggest that once the smoking
habit is firmly established daily individual nicotine intakes
are likely to continue for many years with little change. Thus
numerous studies have shown that when individuals change
to smoking brands of cigarettes with reduced nicotine yields
they rapidly alter their mode of smoking (compensate) so as
to obtain their former accustomed daily nicotine intakes (for
references see Withey et al., 1992). The fact that urinary
TNM/creatinine ratios of samples obtained when the cohort
was enrolled into the study correlated well with those
obtained a year later provides objective evidence for the
assumption that these reflected the chronic smoking habits of
the women in the cohort. Furthermore, the fact that the
tar-nicotine ratios of most brands of cigarettes are very
similar (Phillips and Waller, 1991), implies that intakes of
carcinogenic tar will be closely related to those of nicotine.
The overall odds ratio of 7.8 for biochemically proven
smokers (Table H) confirms the cotinine-based evidence pres-
ented in our companion paper (De Waard et al., 1995) and
supports the conclusion of Garfinkel and Stellman (1988)
that after allowing for the duration of smoking, womenPlearne metabolits and lung cancer risk
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probably have a lung cancer risk of similar magnitude to that
encountered by men.
The results presented in Table III confirm the cotimnne-
based findings reported and discussed in our companion
paper (De Waard et al., 1995) that the relationship between
smoking and adenocarcinoma of the lung is much weaker
than that of other histological types.
The biochemical epidemiology approach used in this
investigation to explore the relationship between smoking
and lung cancer could profitably be employed in the study of
other smoking-related conditions such as ischaemic heart
disease, and also to overall mortality in situations where
appropriate urine banks are available. The great advantage
of this approach is that it does not require either histories of
active smoking or evidence concerning potential exposure to
environmental tobacco smoke.
Unrne samples can be rapidly tested by the qualitative
diethylthiobarbitunic acid extraction procedure (Peach et al.,
1985) and the dose dependence of disease in the active
smokers explored by determiining the TNM creatinine ratios
by the automated colorimetric method of Puhakainen et al.
(1987). The possible influence of passive smoking can then be
assessed using cotinine-based assays (Wald et al.. 1984: De
Waard et al.. 1995).
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